China Pharma Hub Corp

Syndevrx Inc., based in Cambridge, MA, is a pioneering company in the emerging field of metabo-oncology, focusing on the intersection of obesity and cancer treatment. The company is developing its lead compound, Evexomostat SDX-7320, to address the critical need for therapies targeting metabolic hormone dysfunction in cancer patients. Their approach recognizes that dysregulated metabolic hormones significantly contribute to cancer progression and treatment resistance. By targeting these underlying metabolic issues, Syndevrx aims to enhance the effectiveness of standard cancer treatments and improve outcomes for patients affected by both cancer and metabolic disorders. Generated from the website

Aviceda Therapeutics, based in Cambridge, MA, focuses on harnessing the body's natural immune system to modulate inflammation. The company utilizes highly selective ligands designed for maximum specificity towards targeted immune cells and diseases. By employing nature's design, Aviceda Therapeutics aims to develop innovative therapeutic solutions that enhance immune responses. Their approach emphasizes precision in targeting, which is crucial for effectively addressing various health conditions. Generated from the website

Johnson & Johnson Innovation Center in Cambridge, MA is a hub for fostering collaboration and partnerships within the healthcare industry. The center provides a platform for innovators and entrepreneurs to connect with resources and expertise to advance healthcare solutions. Through its strategic programs and initiatives, Johnson & Johnson Innovation Center supports the development of cutting-edge technologies and therapies that aim to improve patient outcomes and address unmet medical needs. Generated from their business information